PT-141 (Bremelanotide)

Catalog preview

PT-141 (Bremelanotide)

A melanocortin receptor agonist studied for its potential role in libido and arousal, used in protocols where PDE5 inhibitors are not the right fit.

Item details are being reviewed. Prices and purchase availability are not final.

Find your starting point →

Know what you're considering.

Overview

Bremelanotide is a synthetic analog of α-melanocyte-stimulating hormone that activates melanocortin receptors in the central nervous system. Research suggests it may modulate pathways involved in sexual desire and arousal, acting upstream of vascular response mechanisms.

Ingredients

Bremelanotide acetate

Use & directions

Compounded subcutaneous injection. Dosing is individualized by your clinician based on response.

Important information.

Side effects

Reported effects include nausea, flushing, headache, transient blood pressure elevation, and skin darkening with extended use. Some patients experience injection-site reactions. Discontinue and notify your clinician if severe hypertension or persistent symptoms develop.

Safety & precautions

Important Safety Information. PT-141 is contraindicated in patients with uncontrolled hypertension or known cardiovascular disease. Use is limited to adults under direct clinician supervision. Not for use during pregnancy.

Read the information for the exact product and formulation. Ask your clinician or pharmacist about suitability, interactions and any questions.

Service & renewal

Review the terms attached to the selected offer before continuing.

Understand service terms →

Shipping

Handling, collection and delivery depend on the product and fulfillment partner.

View shipping information →

Questions

Keep health questions in your secure portal. Support can help with general ordering questions.

Get help →